PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

ORLActivation Mediates a Novel ORLReceptor Agonist SCH221510 Analgesia in Neuropathic Pain in Rats.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30074175 ↗2018Reported benefit

ORLActivation Mediates a Novel ORLReceptor Agonist SCH221510 Analgesia in Neuropathic Pain in Rats.

RatOtherSprague-DawleyMaleIntrathecal3, 10 and 30 microgramTested on day 7 after chronic constriction injury surgery

Model: Chronic constriction injury of the sciatic nerve producing neuropathic pain

Intrathecal SCH221510 dose-dependently reduced thermal and mechanical hypersensitivity after chronic constriction injury. The analgesia was blocked by the ORL1 antagonist and by intrathecal ORL1 siRNA, indicating that it is mediated by spinal ORL1 activation.

Extraction: extract · Supplied extraction confidence: 0.78. Machine-extracted fields require source verification.